NDLI: Characterisation of Ilomastat for Prolonged Ocular Drug Release

Content Provider	Springer Nature Link
Author	Parkinson, Gary Gaisford, Simon Ru, Qian Lockwood, Alastair Khalili, Ashkan Sheridan, Rose Khaw, Peng T. Brocchini, Steve Fadda, Hala M.
Copyright Year	2012
Abstract	We are developing tablet dosage forms for implantation directly into the subconjunctival space of the eye. The matrix metalloproteinase inhibitor, ilomastat, has previously been shown to be efficacious at suppressing scarring following glaucoma filtration surgery (GFS). We report on the physical characterisation of ilomastat which is being developed for ocular implantation. Since ilomastat is being considered for implantation it is necessary to examine its polymorphs and their influence on aspects of the in vitro drug release profile. X-ray powder diffraction identified two polymorphs of ilomastat from different commercial batches of the compound. Tablets were prepared from the two different polymorphs. Isothermal perfusion calorimetry was used to show that amorphous content is not increased during tablet formulation. The melting points of the two polymorphs are 188 and 208°C as determined by differential scanning calorimetry. Utilising single crystal X-ray diffraction, the structural conformations and packing arrangements of the different polymorphs were determined. The orthorhombic crystal crystallised as a monohydrate while the second monoclinic crystal form is non-solvated. Ilomastat tablets prepared from the two different solid forms exhibited similar drug release profiles in vitro under conditions mimicking the aqueous composition, volume and flow of the subconjunctival space after GFS. This suggests that a reproducible dose at each time point during release after implantation should be achievable in vivo with ilomastat tablets prepared from the two polymorphs identified.
Starting Page	1063
Ending Page	1072
Page Count	10
File Format	PDF
Journal	AAPS PharmSciTech
Volume Number	13
Issue Number	4
e-ISSN	15309932
Language	English
Publisher	Springer US
Publisher Date	2012-08-18
Publisher Institution	American Association of Pharmaceutical Scientists
Publisher Place	Boston
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Pharmacy Biotechnology Biochemistry Pharmacology/Toxicology
Content Type	Text
Resource Type	Article

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex

Ocular Drug Delivery

Evaluation of alginate compressed matrices as prolonged drug delivery systems

Formulation, Characterisation and Stabilisation of Buccal Films for Paediatric Drug Delivery of Omeprazole

Temperature-Tunable Iron Oxide Nanoparticles for Remote-Controlled Drug Release

The Drug Release Study of Ceftriaxone from Porous Hydroxyapatite Scaffolds

Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation

An Oral-Controlled Release Drug Delivery System for Liquid and Semisolid Drug Formulations

Ciprofloxacin as Ocular Liposomal Hydrogel

Characterisation of Ilomastat for Prolonged Ocular Drug Release

Similar Documents

Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex

Ocular Drug Delivery

Evaluation of alginate compressed matrices as prolonged drug delivery systems

Formulation, Characterisation and Stabilisation of Buccal Films for Paediatric Drug Delivery of Omeprazole

Temperature-Tunable Iron Oxide Nanoparticles for Remote-Controlled Drug Release

The Drug Release Study of Ceftriaxone from Porous Hydroxyapatite Scaffolds

Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation

An Oral-Controlled Release Drug Delivery System for Liquid and Semisolid Drug Formulations

Ciprofloxacin as Ocular Liposomal Hydrogel

Characterisation of Ilomastat for Prolonged Ocular Drug Release